-
Chardan Capital Reiterates "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN)
来源: Buzz FX / 18 3月 2025 10:31:16 America/New_York
Chardan Capital Reiterates "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN) Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Dyne Therapeutics ( NASDAQ:DYN - Get Free Report ) 's stock had its "buy" rating rest
Read more...